A61K 31 - Medicinal preparations containing organic active ingredients

Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
11/2006
11/08/2006	EP1718649A2 Imidazo 1,2-c pyrimidinylacetic acid derivatives
11/08/2006	EP1718648A1 Tricyclic imidazopyridines and intermediates for the synthesis thereof
11/08/2006	EP1718647A1 Prodrugs of substituted amino heterobicycles which modulate the function of the vanilloid-1 receptor (vr1)
11/08/2006	EP1718646A1 1,2,4-triazolo[4,3-a]pyridines useful in the treatment of gastrointestinal disorders
11/08/2006	EP1718645A1 2-(pyridin-3-ylamino)-pyrido 2,3-d pyrimidin-7-ones
11/08/2006	EP1718643A1 Indazole-carboxamide compounds as 5-ht4 receptor agonists
11/08/2006	EP1718641A2 Benzimidazole derivative and its use as aii receptor antagonist
11/08/2006	EP1718640A1 Novel crystalline forms of conazoles and methods of making and using the same
11/08/2006	EP1718637A2 Benzimidazolyl derivatives as kinase inhibitors
11/08/2006	EP1718636A1 New compounds useful for the synthesis of s- and r-omeprazole and a process for their preparation
11/08/2006	EP1718635A1 Piperidinyl targeting compounds that selectively bind integrins
11/08/2006	EP1718634A1 Piperidine derivatives
11/08/2006	EP1718633A1 N-type calcium channel blockers
11/08/2006	EP1718632A1 Pyrimidine derivatives as orexin receptor antagonists
11/08/2006	EP1718631A2 Cytotoxin compound and method of isolation
11/08/2006	EP1718630A1 DIBENZO CHROMENE DERIVATIVES AND THEIR USE AS ER&bgr; SELECTIVE LIGANDS
11/08/2006	EP1718628A1 Cinnamic amides, process for their preparation, and pharmaceutical compositions containing them
11/08/2006	EP1718626A1 Sulfonylpyrrolodine modulators of androgen receptor fuction and method
11/08/2006	EP1718625A1 Compounds
11/08/2006	EP1718624A1 Benzamide derivatives and their use as glucokinase activating agents
11/08/2006	EP1718623A1 Compounds as inhibitors of cell proliferation and viral infections
11/08/2006	EP1718620A1 Pyrimidine derivatives as cannabinoid receptor modulators
11/08/2006	EP1718619A1 Substituted pyrazoline compounds for reducing triglycerides in blood
11/08/2006	EP1718618A1 Pyrazoline derivatives useful for the treatment of cancer
11/08/2006	EP1718617A2 3-substituted 1,5-diphenylpyrazole derivatives useful as cb1 modulators3-substituted 1,5-diphenylpyrazole derivatives useful as cb1 modulators
11/08/2006	EP1718616A2 Isoquinoline derivatives
11/08/2006	EP1718615A1 Novel quinoline-carbaxamides as jack3 kinase modulators
11/08/2006	EP1718614A1 Pyridinamide derivative as kinase inhibitors
11/08/2006	EP1718613A1 Pyridine derivatives and their use as cb2 receptor modulators
11/08/2006	EP1718612A1 Novel benzofurans and indols
11/08/2006	EP1718610A1 Pyrrole-3-carboxamide derivatives for the treatment of obesity
11/08/2006	EP1718609A1 Substituted azetidine compounds, their preparation and use as medicaments
11/08/2006	EP1718608A1 Viral polymerase inhibitors
11/08/2006	EP1718607A1 Modafinil compositions
11/08/2006	EP1718604A1 Immunosuppressant compounds and compositions
11/08/2006	EP1718603A2 Nitric oxide-releasing molecules
11/08/2006	EP1718602A1 Therapeutic and carrier molecules
11/08/2006	EP1718568A2 Process for preparing water soluble diterpenes and their applications
11/08/2006	EP1718367A1 Muc1 antagonist enhancement of death receptor ligand-induced apoptosis
11/08/2006	EP1718340A2 New effector conjugates, process for their production and their pharmaceutical use
11/08/2006	EP1718337A1 New combinations of an anti emetic agent and an enkephalinase inhibitor
11/08/2006	EP1718336A2 Novel combination of anticholinergic and beta mimetics for the treatment of respiratory diseases
11/08/2006	EP1718335A2 Drug conjugates
11/08/2006	EP1718334A2 Methods of diagnosing and treating pre-eclampsia or eclampsia
11/08/2006	EP1718333A2 Methods of modulating cd200 and cd200r
11/08/2006	EP1718326A2 New pharmaceutical compositions based on benzilic acid esters and soluble tnf receptor fusion proteins
11/08/2006	EP1718322A2 Antitumor agent
11/08/2006	EP1718316A2 Nitric oxide-releasing polymers
11/08/2006	EP1718315A1 High dose, short interval use of sulfated polysaccharides for the treatment of infections
11/08/2006	EP1718314A1 Heparin for the treatment of ocular pathologies
11/08/2006	EP1718313A1 Synergistic anti-inflammatory pharmaceutical compositions and methods of use
11/08/2006	EP1718312A2 Synergistic anti-inflammatory pharmaceutical compositions and related methods using curcuminoids or methylxanthines
11/08/2006	EP1718311A1 Therapeutic combinations of atypical antipsychotics with corticotropin releasing factor antagonists
11/08/2006	EP1718309A2 Anorectic compounds
11/08/2006	EP1718308A2 Methods of modulating neurotrophin-mediated activity
11/08/2006	EP1718307A2 Immunosuppressant compounds and compositions
11/08/2006	EP1718306A2 Modulation of inflammatory and metastatic processes
11/08/2006	EP1718305A1 Pyrimidine derivatives and use thereof as agricultural and horticultural fungicides
11/08/2006	EP1718304A1 Pharmaceutical compositions based on anticholinergics and pegsunercept
11/08/2006	EP1718303A2 Combination of proton pump inhibitor, buffering agent, and nonsteroidal anti-inflammatory agent
11/08/2006	EP1718302A1 Organic compounds
11/08/2006	EP1718301A1 Pharmaceutical compositions based on anticholinergics and pegsunercept
11/08/2006	EP1718300A2 Conformationally constrained smac mimetics and the uses thereof
11/08/2006	EP1718299A1 Heterocyclic gaba-a subtype selective receptor modulators
11/08/2006	EP1718298A2 Process for making ep4 agonists and intermediates thereof
11/08/2006	EP1718297A2 Novel chemical compounds
11/08/2006	EP1718296A2 Use of metronidazole for preparing a pharmaceutical composition for treating pathologies related to the b-type receptor of interleukin 8 and/or to a pacap type 1 receptor
11/08/2006	EP1718295A2 Use of metronidazole for preparing a pharmaceutical composition for treating a cutaneous inflammation
11/08/2006	EP1718294A1 Methods for treatment of complications of diabetes
11/08/2006	EP1718293A1 Oxydecahydronaphthalene modulators of hm74
11/08/2006	EP1718292A1 Furosemide derivatives as modulators of hm74 and their use for the treatment of inflammation disorders
11/08/2006	EP1718291A1 Use of cholinesterase inhibitors for treating vascular depression
11/08/2006	EP1718290A1 Composition, comprising l-serine, l-isoleucine, folic acid and trace elements, for treating psoriasis
11/08/2006	EP1718289A2 Therapeutic methods employing nitric oxide precursors
11/08/2006	EP1718288A1 Solid formulations of ospemifene
11/08/2006	EP1718287A1 Method for treatment or prevention of osteoporosis in individuals with high bone turnover
11/08/2006	EP1718286A2 Nitrosated and/or nitrosylated compounds, compositions and methods of use
11/08/2006	EP1718285A2 Use of a compound modulating at least one receiver selected in a group comprising an interleukin 8 type b receptor and pacap-1 receptor for preparing a pharmaceutical composition for rosacea treatment
11/08/2006	EP1718284A2 Susceptibility gene for myocardial infraction, stroke, and paod; methods of treatment
11/08/2006	EP1718283A2 Topical co-enzyme q10 formulations and methods of use
11/08/2006	EP1718281A1 Multilayer tablet
11/08/2006	EP1718280A2 Methods and compositions for treating cancer
11/08/2006	EP1718276A2 Inhalant formulation containing sulfoalkylether cyclodextrin and corticosteroid prepared from a unit dose suspension
11/08/2006	EP1718273A2 Compositions comprising vitamins and/or derivatives thereof stabilised with olea europea extract and/or ionene polymers
11/08/2006	EP1718258A2 Abuse resistant opioid transdermal delivery device containing opioid antagonist microspheres
11/08/2006	EP1718201A1 Substituted porphyrins
11/08/2006	EP1718152A2 Aminocyclopentyl pyridopyrazinone modulators of chemokine receptor activity
11/08/2006	EP1718151A2 Nicotine receptor agonists in stem cell and progenitor cell recruitment
11/08/2006	EP1718150A1 Methylation inhibitor compounds
11/08/2006	EP1718149A2 SYSTEM IMMUNE ACTIVATION METHOD USING NON CpG NUCLEIC ACIDS
11/08/2006	EP1718146A2 Compositions and methods used to treat acne and candida
11/08/2006	EP1691796A4 Terrein compound having melanin biosynthesis inhibitors and its preparation
11/08/2006	EP1669379A4 3,5-dimethyl-1-adamantyl-ammonium polymeric salts and the use thereof in the form of antiviral agents
11/08/2006	EP1653933B1 Dermal or transdermal therapeutic system comprising an ormocer with barrier effect on a cover foil
11/08/2006	EP1649286A4 Improved aminodextran compositions and conjugates and methods of making and using them
11/08/2006	EP1587810B1 Novel substituted 1,4\|benzodioxino 2,3-e\|isoindole derivatives, method for preparing same and pharmaceutical compositions containing same
11/08/2006	EP1539742B1 Indole derivatives useful as histamine h3 antagonists
11/08/2006	EP1494749B1 Process for preparation of pharmaceutical composition containing antiretroviral protease inhibitor with improved bioavailability
11/08/2006	EP1465604A4 Co-processed carbohydrate system as a quick-dissolve matrix for solid dosage forms
11/08/2006	EP1455771B1 2-indanylamino derivatives for the therapy of chronic, acute or inflammatory pain

1 ... 4017 4018 4019 4020 4021 4022 4023 4024 4025 4026 4027 4028 4029 4030 4031 4032 4033 4034 4035 4036 4037 ... 7860